Original Article
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jul 28, 2014; 20(28): 9486-9496
Published online Jul 28, 2014. doi: 10.3748/wjg.v20.i28.9486
Table 1 Baseline clinical characteristics of the different therapy groups and healthy controls
HCs (n = 14)LAM (n = 28)LDT (n = 24)P (LAM vs LDT)
Sex ratio (male/female)11:326:218:6NS
Age (mean ± SD)40 ± 11.439.86 ± 10.934.71 ± 8.40NS
ALT median (U/L, range)30 (30-34)145 (60-453)227 (60-957)NS
AST median (U/L, range)23 (17-30)87.5 (20-274)129.5 (29-585)NS
TBil median (μmol/L, range)4.0 (3.0-7.0)19.25 (7.7-35.6)37.5 (35-47)NS
Median albumin (g/dL, range)3.6 (2.4-4.4)3.7 (3.4-4.7)NS
HBV DNA (Log10 IU/mL) (mean ± SD)6.28 ± 0.785.85 ± 0.64NS
HBeAg (PEIU/mL) (mean ± SD)46.53 ± 48.6353.91 ± 83.59NS